BF

Brendan Frey

CEO

Deep Genomics

Toronto, Ontario


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Deep Genomics
Industry
research
Employees
88.0
Seniority
C suite
Annual Revenue
5000000.0
Total Funding
236700000.0
Latest Funding
Series C

Technologies

Route 53 Gmail Google Apps Microsoft Office 365 DigitalOcean Lever Mapbox YouTube Nginx Mobile Friendly Google Tag Manager Google Analytics Google Font API Google Maps Google Maps (Non Paid Users) Remote Circle AI

Keywords

biotechnology research ai platform rna therapeutics drug development genetic conditions biopharmaceutical company artificial intelligence foundation model bigrna machine learning drug discovery rna biology target identification therapeutic candidates rna expression prediction genomic variants regulatory mechanisms steric blocking oligonucleotides gene editing dna sequencing deep learning computational biology drug mechanisms biotech innovation genetic medicine pathogenic variants molecular biology clinical development rna editing cell models biological mechanisms genomic signals biotechnology rna binding proteins microrna discovery oligonucleotide therapeutics therapeutic discovery automation in biology biomedical breakthroughs pharmaceutical development precision medicine in vitro models genetic analysis biomedical research rna therapeutic modalities genetic research nucleic acid science therapeutic design deep genomics ai-driven drug candidates predictive systems genetic therapies rare diseases complex genetic disorders therapeutic targets rna-based therapies genetic variants therapeutic development healthcare professionals biotech companies pharmaceutical firms research institutions collaboration opportunities exscientia insitro personalized medicine drug candidate database ai workbench genetic insights innovation scalability patient outcomes information technology & services

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans